Jane Street’s Cardiol Therapeutics CRDL Stock Holding History

Jane Street’s Portfolio CRDL Stock Details CRDL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$56.1K	Sell	53,416 -73,541	-58%	-$93.1K	﹤0.01%	10886
2026 Q1	$172K	Buy	126,957 +87,129	+219%	+$89.4K	﹤0.01%	10275
2025 Q4	$38K	Sell	39,828 -76,519	-66%	-$80.1K	﹤0.01%	10579
2025 Q3	$126K	Buy	+116,347	New	+$141K	﹤0.01%	10009
2024 Q4	–	Sell	-14,759	Closed	-$29.4K	–	9541
2024 Q3	$29.4K	Buy	+14,759	New	+$30.6K	﹤0.01%	9252
2023 Q2	–	Sell	-20,875	Closed	-$10.2K	–	8782
2023 Q1	$10.2K	Sell	20,875 -42,198	-67%	-$25K	﹤0.01%	8734
2022 Q4	$32.1K	Buy	+63,073	New	+$38.4K	﹤0.01%	8486
2022 Q2	–	Sell	-36,576	Closed	-$57K	–	9775
2022 Q1	$57K	Sell	36,576 -16,220	-31%	-$26.8K	﹤0.01%	9649
2021 Q4	$97K	Sell	52,796 -26,635	-34%	-$73.6K	﹤0.01%	9264
2021 Q3	$327K	Buy	+79,431	New	+$288K	﹤0.01%	8018

Other funds holding CRDL

MMCAP International Grand Cayman, Cayman Islands $1.18B AUM 50.44% 1-Year Est. Return

Tejara Capital London, United Kingdom $243M AUM 9.84% 1-Year Est. Return

Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return

BFM

Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Integrity Alliance Urbandale, Iowa $3.2B AUM 23.28% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Jane Street's CRDL Position: Q2 2026 in Review

Jane Street reduced its Cardiol Therapeutics (CRDL) stake by 58% in Q2 2026, selling an estimated $93.1K and leaving 53,416 shares worth $56.1K. The position accounts for ﹤0.01% of the portfolio, ranked #10886.

Jane Street first reported a position in CRDL in Q3 2021 and has held it in 10 quarters since. The position peaked at $327K in Q3 2021. 52 funds tracked by Wall St. Rank hold CRDL as of Q2 2026.

Jane Street held 53,416 shares of Cardiol Therapeutics worth $56.1K as of Q2 2026.
Jane Street sold 73,541 Cardiol Therapeutics shares in Q2 2026, an estimated $93.1K.
Cardiol Therapeutics made up ﹤0.01% of Jane Street's portfolio in Q2 2026, its #10886 holding.
Jane Street first reported a position in Cardiol Therapeutics in Q3 2021 and has held it in 10 quarters since.
Jane Street's Cardiol Therapeutics position peaked at $327K in Q3 2021.
52 funds tracked by Wall St. Rank held Cardiol Therapeutics as of Q2 2026.

Based on Jane Street's 13F filing for Q2 2026, filed 14 Aug 2026.